U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 2

1.
Figure 2

Figure 2. From: Clinical application of biological markers for treatments of resectable non-small-cell lung cancers.

Overall survival of patients with stage II–III NSCLCs in relation to biological markers. (A) Ki-67 index, (B) tumour vascularity, (C) TS status, (D) TS status and UFT-based chemotherapy, (E) VEGF-A status, (F) VEGF-C status, and (G) E-cadherin status.

C Huang, et al. Br J Cancer. 2005 Apr 11;92(7):1231-1239.
2.
Figure 1

Figure 1. From: Clinical application of biological markers for treatments of resectable non-small-cell lung cancers.

Overall survival of patients with stage I NSCLCs in relation to biological markers. (A) Ki-67 index, (B) tumour vascularity, (C) TS status, (D) TS status and UFT-based chemotherapy, (E) VEGF-A status, (F) VEGF-C status, and (G) E-cadherin status.

C Huang, et al. Br J Cancer. 2005 Apr 11;92(7):1231-1239.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center